Effect of Covid-19 engagement of ACE2 on brain health and pathology

Covid-19 与 ACE2 的结合对大脑健康和病理学的影响

基本信息

  • 批准号:
    10151985
  • 负责人:
  • 金额:
    $ 19.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-12-08 至 2022-06-30
  • 项目状态:
    已结题

项目摘要

Abstract There are mechanisms in the brain that regulate interactions between neurons and microglial cells and promote homeostasis. These are perturbed in several diseases including neuropsychiatric lupus, NPSLE, studied in this PPG, and following sepsis. Many conditions of neuroinflammation are characterized by microglial activation, and, as a consequence of this activation, by neuronal dendritic pruning and an impaired blood brain barrier. Interestingly, a pathway regulating homeostasis in the brain and dysregulated by neuroinflammation is the renin-angiotensin system. Angiotensin II is generated by angiotensin converting enzyme, ACE, and binds to a receptor AT-1 to enhance inflammation. ACE inhibitors or angiotensin receptor blockers, ARBs, can improve neuroinflammation by either decreasing production or neutralizing angiotensin II. In this pathway, ACE2, a membrane-bound protease, also functions to destroy angiotensin and to generate a small angiotensin peptide, ang1-7, that is anti-inflammatory. ACE2 is the cellular receptor for Covid-19, and binds the viral spike protein, S, more specifically, the receptor binding domain, RBD. This study will examine the binding of S and RBD to normal mouse brain and to mouse brain mimicking NPSLE or sepsis survival. We will further study whether engagement by S or RBD alters the functional state of neurons, microglia and brain endothelial cells. Finally, we ask whether the use of ACE inhibitors or ARBs alters S or RBD binding, and whether S or RBD impair the efficacy of these medications in halting or reversing the neurodegenerative process in NPSLE and in sepsis survivors. This study cannot be performed in humans, but it has important translational implications.
摘要 大脑中有调节神经元和小胶质细胞之间相互作用的机制。 细胞和促进动态平衡。它们在几种疾病中受到干扰,包括 神经精神性狼疮,NPSLE,在这个PPG中研究,并在脓毒症后。许多情况下 神经炎症的特征是小胶质细胞的激活,因此 通过神经元树突修剪和血脑屏障受损而激活。有趣的是,一个 调节大脑内动态平衡和神经炎症失调的途径是 肾素-血管紧张素系统。血管紧张素II由血管紧张素转换酶、血管紧张素转换酶、 并与受体AT-1结合以增强炎症。血管紧张素转换酶抑制剂或血管紧张素受体 阻滞剂,ARB,可以通过减少产生或中和来改善神经炎症 血管紧张素II。在这一途径中,ACE2,一种膜结合的蛋白酶,也起到破坏 血管紧张素和产生一种抗炎的小血管紧张素,Ang1-7。 血管紧张素转换酶2是新冠肺炎的细胞受体,与病毒尖峰蛋白S结合,更具体地说, 受体结合域,RBD。本研究将考察S和红斑狼疮与正常人的结合 小鼠脑和小鼠脑模拟NPSLE或脓毒症存活。我们将进一步研究 S或RBD参与是否改变神经元、小胶质细胞和脑的功能状态 内皮细胞。最后,我们询问血管紧张素转换酶抑制剂或ARB的使用是否会改变S或RBD 结合,以及S或RBD是否损害这些药物的止血或逆转作用 NPSLE和脓毒症幸存者的神经退变过程。这项研究不能 在人类身上进行,但它具有重要的翻译意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Betty Diamond其他文献

Betty Diamond的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Betty Diamond', 18)}}的其他基金

Origin and function of atypical lymphocyte populations in inflamed tissue in SLE and RA
SLE 和 RA 炎症组织中非典型淋巴细胞群的起源和功能
  • 批准号:
    10088788
  • 财政年份:
    2021
  • 资助金额:
    $ 19.65万
  • 项目类别:
Origin and function of atypical lymphocyte populations in inflamed tissue in SLE and RA
SLE 和 RA 炎症组织中非典型淋巴细胞群的起源和功能
  • 批准号:
    10427145
  • 财政年份:
    2021
  • 资助金额:
    $ 19.65万
  • 项目类别:
Origin and function of atypical lymphocyte populations in inflamed tissue in SLE and RA
SLE 和 RA 炎症组织中非典型淋巴细胞群的起源和功能
  • 批准号:
    10598097
  • 财政年份:
    2021
  • 资助金额:
    $ 19.65万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10397088
  • 财政年份:
    2019
  • 资助金额:
    $ 19.65万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10159860
  • 财政年份:
    2019
  • 资助金额:
    $ 19.65万
  • 项目类别:
Alteration of function and specificity of TFH in SLE
SLE 中 TFH 功能和特异性的改变
  • 批准号:
    10650347
  • 财政年份:
    2019
  • 资助金额:
    $ 19.65万
  • 项目类别:
Alteration of function and specificity of TFH in SLE
SLE 中 TFH 功能和特异性的改变
  • 批准号:
    9973185
  • 财政年份:
    2019
  • 资助金额:
    $ 19.65万
  • 项目类别:
Alteration of function and specificity of TFH in SLE
SLE 中 TFH 功能和特异性的改变
  • 批准号:
    10196943
  • 财政年份:
    2019
  • 资助金额:
    $ 19.65万
  • 项目类别:
Alteration of function and specificity of TFH in SLE
SLE 中 TFH 功能和特异性的改变
  • 批准号:
    10437692
  • 财政年份:
    2019
  • 资助金额:
    $ 19.65万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10617661
  • 财政年份:
    2019
  • 资助金额:
    $ 19.65万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.65万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.65万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.65万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.65万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.65万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.65万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.65万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.65万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.65万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.65万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了